---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-123056"
form_type: "8-K"
ticker: "NOTV"
cik: "0000720154"
company_name: "Inotiv, Inc."
filed_at: "2022-11-30T23:59:59+00:00"
generated_at: "2026-06-21T11:54:55.116017+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Inotiv announces additional site consolidation plans in U.S. and proposed consolidation in Europe and U.K.

## Summary
- Closing two isolator facilities in Indianapolis, IN, consolidating into existing U.S. facilities by end of fiscal year 2023.
- Proposes consolidation of facilities in Gannat, France and Blackthorn, U.K. into Horst, Netherlands and Hillcrest, U.K., pending consultation with employee representatives.
- Completed site closures at Cumberland, VA (Sept 2022) and Dublin, VA (Nov 2022); purchase agreement in place for Dublin facility.
- Closure of Haslett, MI and Boyertown, PA facilities proceeding; expected to close by end of Q2 fiscal 2023 and be made available for sale.
- CEO Robert Leasure expects the consolidations to enhance margins and reduce anticipated capital expenditure needs at closing sites.

## SEC filing metadata
- accession: 0001104659-22-123056
- form_type: 8-K
- ticker: NOTV
- cik: 0000720154
- company_name: Inotiv, Inc.
- filed_at: 2022-11-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/720154/000110465922123056/0001104659-22-123056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/720154/000110465922123056/tm2231601d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-123056
- JSON: https://secwatch.observer/filing/0001104659-22-123056.json
- Plain text: https://secwatch.observer/filing/0001104659-22-123056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.